Current and Future Clinical Applications of Fluid Biomarkers in Alzheimer's Disease
Tracking # 20-1123054
Price not reported
There are no ratings for this course
Learn moreCourse overview
Various biomarkers for Alzheimer's Disease pathology are now available to support the diagnostic journey of individuals presenting with symptoms of cognitive impairment. Discover an update regarding the rapidly evolving landscape of CSF and blood-based biomarkers of Alzheimer's disease pathology. Explore the presenters' experiences with CSF biomarkers' adoption and dive into future blood-based biomarker implementation in clinical practice following appropriate use recommendations.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Alicia Algeciras-Schimnich:
- Board/Committee Membership/Advisory Board: Roche Diagnostics, Fujirebio Diagnostics, Siemens Healthineers
- Presenter/Speaker: Roche Diagnostics
- Melissa Budelier:
- Presenter/Speaker: Roche Diagnostics, BioRad, Waters
- Intellectual Property/Royalty Income: Patents for (1) Multiplexed Assay and Methods of Use Thereof and (2) CSF and Plasma Neurofilament Light Chain Mass Spectrometry Assay.